Clinical Trial Update: DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

View source ↗

Summary

The DEFENDO long-term follow-up study in Stage 1 Neurotrophic Keratitis patients has completed enrollment and posted results on 2025-11-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• DEFENDO

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Neurotrophic Keratitis | Status: COMPLETED | Results posted: 2025-11-28